Adiponectin has been shown to exert anti-tumor effects (55, 56), and its levels are inversely correlated with a number of different cancers, such as myeloma, breast, prostate, colon, and endometrial cancer (57, 58), and are associated with poor prognosis (59). This evidence concerns the gene ADIPOQ and cancer.